Patient no. | Tumor site | TNM at diagnosis | Tumor stage | Differentiation | Type and doses of RT (Gy) | Survival in months |
---|---|---|---|---|---|---|
1 | supraglottic larynx | T1N0M0 | I | well | definitive/68.7 | 28* |
2 | supraglottic larynx | T2N0M0 | II | moderate | definitive/70.0 | 52* |
3 | oral cavity | T3N2M0 | IV | poor | preoperative/63.4 | 4* |
4 | oral cavity | T4N1M0 | IV | moderate | preoperative/62.3 | 10* |
5 | hypopharynx | T1N3M0 | IV | poor | preoperative/62.3 | 32* |
6 | oral cavity | T4N2M0 | IV | moderate | preoperative/63.0 | 17* |
7 | glottic larynx | T2N0M0 | II | moderate | definitive/70.0 | 64 |
8 | hypopharynx | T4N1M0 | IV | poor | preoperative/44.0 | 7* |
9 | oropharynx | T3N2M0 | IV | moderate | preoperative/60.0 | 12* |
10 | oral cavity | T2N0M0 | II | well | preoperative/64.6 | 63 |
11 | nasopharynx | T3N0M0 | III | poor | preoperative/63.6 | 70 |
12 | nasopharynx | T3N2M0 | III | poor | definitive/68.4 | 59 |
13 | oropharynx | T1N2M0 | IV | moderate | preoperative/62.4 | 59 |
14 | oropharynx | T4N2M0 | IV | moderate | preoperative/61.5 | 6* |
15 | oral cavity | T2N0M0 | II | poor | preoperative/64.0 | 58 |